FAS and cancer: Recent studies have shown that neutrophils discharge catalytically active NE, thus directly killing cancer cells, and attenuating tumorigenesis through proteolytically freeing the CD95 death domain in tumor cells, which in turn interacts with histone H1 isoforms and selectively leads to cancer cell apoptosis96,109.